Macrophage (Mf)-based vectors are highly mobile cellular shuttles designed to deliver therapeutic genes within the tissues. We engineered a mouse Mf cell line to express the murine interferon-g (IFNg) under the control of an inducible promoter containing the hypoxia-responsive element, which can be triggered by hypoxia and other stimuli. We show that this Mf vector can be induced to produce IFNg under normoxic conditions by stimulation with picolinic acid (PA), a catabolite of tryptophan, or desferrioxamine (DFX), an ironchelating drug. The Mf vector responds to IFNg with the induction of IRF-1 and of other IFNg-inducible genes, the expression of Ia antigens and induction of phagocytic activity.
Introduction
The future of gene therapy depends, to a large extent, on the identification of better and more effective vectors to deliver therapeutic genes inside the tissues. We are studying Mf-based vectors that exploit the mobility of these cells to deliver exogenous genes to the tissues. Mononuclear phagocytes are ubiquitous, circulating cells that can extravasate and infiltrate most of the tissues, and their ability to come into close contact with the tissue components renders them excellent candidate cellular vectors for gene therapy. 1 In general, Mf vectors can be designed to express the relevant therapeutic gene, to infiltrate the target tissue and secrete the therapeutic molecule in close proximity of the host cells.
Mf cell lines and primary Mf or dendritic cells (DCs) engineered to express tumor-specific antigens or immunoregulatory cytokines have been employed for adoptive immunotherapy. 2, 3 We demonstrated that Mf vectors can deliver an infectious retrovirus carrying a marker gene within the host tissue and can transduce the host with the virus. 4 The possibility of designing retroviral vectors selective for hematopoietic stem cells and Mf was reported recently. 5 Mf vectors can also utilize the expression of their functional activities for therapeutic applications when engineered to produce Mfactivating factors. For example, human monocytes 6 or murine Mf 7, 8 activated by the expression of the engineered interferon-g (IFNg) gene were shown to exert immunostimulatory and antitumor activities.
Mf vectors are not tissue specific and should be endowed with conditional systems to control the expression of therapeutic genes. A common denominator of many pathological lesions is hypoxia, a condition of low oxygen tension that occurs, for example, within the tumor mass or in inflammatory areas. Mf respond to hypoxia 9, 10 and can be engineered to express therapeutic genes under these conditions 11, 12 using synthetic promoters containing the hypoxia-responsive element (HRE), which is specifically transactivated under hypoxic conditions (reviewed in Lewis et al 10 and Semenza 13 ). The hypoxic environment inhibits oxygen-dependent pathways such as the generation of nitric oxide, 14 thereby limiting the therapeutic potential of hypoxia-sensitive Mf vectors. Therefore, it is important to develop strategies allowing the expression of the hypoxia-driven therapeutic gene under normoxic conditions utilizing stimuli or drugs, other than hypoxia, which can be delivered in a controlled manner. One group of these compounds is represented by metal chelators including desferrioxamine (DFX), 15, 16 a drug used to treat iron overload, and picolinic acid (PA), 9 a metabolite of tryptophan. The Mf-activating properties of PA have been studied extensively. Although the drug by itself is not very active on these cells, it is a powerful costimulator of Mf activation when used in combination with IFNg. 17 We studied Mf vector expressing IFNg under the control of HRE and we show that these Mf can be fully activated by stimulation with PA or DFX under normoxic conditions.
Results
We transfected the ANA-1 Mf cell line with the pHRE3x-Tk-IFNg vector expressing the murine IFNg gene under the control of the synthetic promoter HRE3x-Tk and the neomycin resistance gene as a selectable marker ( Figure 1 ) to generate a Mf cell line producing IFNg in response to PA or DFX. The cells were selected in medium containing neomycin, and the neomycin-resistant Mf (HRE-IFN-Mf) were tested for IFNg mRNA expression and protein secretion following stimulation for 6 or 24 h with PA, DFX or hypoxia. PA and DFX were used at the optimal concentration of 4 mM and of 400 mM, respectively, as established previously. 18, 19 Control cultures (Contr-Mf) were tested in parallel experiments.
IFNg mRNA was upregulated by PA or DFX treatment in a time-dependent manner (Figure 2a) , and parallel increase in IFNg release into the supernatant was detected (Figure 2b ). We consistently observed inducibility of IFNg secretion in response to PA or DFX stimulation, which ranged from 5-to 15-fold over control in four independent experiments. In contrast, Contr-Mf or parental ANA-1 cells were negative for both IFNg mRNA expression and protein secretion either constitutively or in response to stimulation (data not shown). The induction of IFNg by hypoxia was weaker and delayed in comparison to PA or DFX (Figure 2a and b) . These results demonstrated that the synthetic promoter HRE3x-Tk was inducible by PA or DFX in stable Mf transfectants, and that the latter two stimuli were more potent than hypoxia in driving the expression of IFNg.
IFNg induces gene expression through the activation of various transcription factors including the interferonresponsive factor-1 (IRF-1), 20 which binds the interferonresponsive element (IRE) present in the promoter of IFNg-responsive genes. 20 To determine whether the secreted IFNg was biologically active, we investigated the expression of IRF-1 protein in HRE-IFN-Mf in response to PA or DFX stimulation (Figure 3a) . Engineered Mf expressed basal levels of IRF-1 that were augmented by PA or DFX. Maximal expression of IRF-1 by PA or DFX was detected at 24 and 6 h, respectively, indicating that the response to DFX was faster than that to PA. Double-stranded RNA-dependent enzymes are induced by every class of IFN and represent a characteristic feature of IFNg-treated cells. The expression of 2 0 -5 0 -oligoadenylate synthase (2 0 -5 0 OAse), an IFNg-inducible double-stranded RNA-dependent enzyme, 20 was analyzed in PA-or DFX-treated cells, and the results are shown in Figure 3b . Two-to four-fold upregulation of 2 0 -5 0 OAse mRNA expression was consistently observed following treatment with PA or DFX for 6 or 24 h. These In contrast, 24 h treatment with PA or DFX caused a reduction in the fraction of cells in the G0/G1 phase and a concomitant increase of the sub-G1 population ( Figure  5b ). These results suggest that PA and DFX may promote some degree of apoptosis in the HRE-IFN-Mf.
Evidence that the antimicrobial effector functions could be evoked in HRE-IFN-Mf was obtained by measuring the phagocytic activity of the cells. Cells were cultured for 18 h in medium alone or in the presence of PA or DFX, followed by incubation for 5 h with opsonized zymosan, and phagocytosis was assessed on Giemsa-stained smears. HRE-IFN-Mf displayed a low spontaneous phagocytic activity that was strongly enhanced by treatment with PA alone (Figure 6a and b). A high phagocytic index was also observed when cells were exposed to DFX (Figure 6a ). Both stimuli were ineffective on control cells (data not shown). Taken together, these data demonstrate that hypoxia-sensitive Mf vectors display immune and effector functions of fully activated Mf upon stimulation with PA or DFX alone.
We have previously reported that exogenous IFNg costimulation is absolutely required for PA-or DFXdependent induction of inducible nitric oxygen synthase (iNOS) and TNFa mRNA in normal murine Mf. 15, 18 We investigated whether IFNg produced endogenously by HRE-IFN-Mf could act synergistically with the costimulatory agents. HRE-IFN-Mf were cultured for different time points in the presence of PA or DFX and then tested for iNOS mRNA expression (Figure 7a ), nitric oxide (NO) production ( Figure 7b ) and TNFa secretion ( Figure  7c ). Hypoxia-sensitive Mf vectors constitutively expressed very low levels of iNOS mRNA and responded to PA or DFX stimulation for 6 h with up to 10-fold iNOS induction, which was further increased with time in culture (Figure 7a ). Accordingly, NO production was undetectable in HRE-IFN-Mf treated for 6 h with either stimulus, but was strongly induced after 24 h treatment (Figure 7b ). TNF-a production is associated with that of iNOS in response to PA and IFNg stimulation. HRE-IFNMf constitutively secreted low amounts of TNFa (0.3570.02 ng/ml), which were appreciably increased by PA (0.6370.02 ng/ml) and DFX (0.8770.02 ng/ml) treatment for 6 h. Stimulation with PA or DFX for 24 h caused a major increase in TNFa production, which reached levels of 270.08 or 1.4270.07 ng/ml, respectively (Figure 7c ), indicating that the extent of IFNg production in response to other stimulus was associated with a parallel increase in the amounts of secreted TNFa. These results demonstrated that PA and DFX could efficiently induce the effector functions of activated Mf.
Iron chelation could account for some of the biological activities of PA and DFX on Mf. 15, 21, 22 To investigate the role of iron chelation on the response of HRE-IFN-Mf to PA and DFX, cells were stimulated for 24 h with PA or DFX, alone or in the presence of different doses of Fe 2 SO 4 , and the expression of IFNg mRNA was analyzed. One representative experiment out of three performed is depicted in Figure 8a . Fe 2 SO 4 inhibited IFNg mRNA induction by PA or DFX, with 100 mM sufficient to decrease the response to PA and 300 mM required to suppress the response to either stimulus. As shown in Figure 8b , the dose of 300 mM Fe 2 SO 4 also completely inhibited the induction of iNOS mRNA expression in PA or DFX. These results demonstrate that full activation of HRE-IFN-Mf involves iron chelation.
Discussion
We explored the potential of Mf vectors to be shuttles for therapeutic genes and also effector cells that can be deliberately activated when needed. We have engineered 
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Mf to express IFNg to combine the paracrine effects of this cytokine on host tissues and the autocrine activity on the Mf vector itself. IFNg was engineered under the control of HRE, and we demonstrate that either function of the Mf vector is inducible by the exogenous, chemically defined molecules, PA or DFX, and further modulated by iron levels.
Activated Mf are important to host defence because they express antimicrobial, antitumor and immunostimulatory activities, and IFNg is a well-known Mf activator. Studies in which DCs, 2 human monocytes, 6 and murine Mf 7 were engineered to express the IFNg gene demonstrated the relevance of this cytokine in cellular gene therapy protocols for treatment of cancer and infection.
Full Mf activation is a multistep process that requires the cooperation of two signals, one derived from the immune system, such as IFNg, and the other from bacterial or viral products or from the tissue environment (eg hypoxia). 1 Activated Mf exert cytotoxic activity 17 mainly though the production of NO. The Mf vector system described in this paper was designed to generate activated macrophages (Mf), because the therapeutic gene (IFNg) is an Mf activator and is expressed in an inducible manner in response to molecules, PA or DFX, which have costimulatory activities on Mf. The inducibility by hypoxia of HREcontaining synthetic promoters was previously characterized in vivo 23, 24 in vitro, 9, 15, 25, 11, 26 and also in Mf. 12, 11 New perspectives in the use of hypoxia-sensitive Mf vectors stem from the observation that stimuli other than hypoxia can activate HRE. 27 Some of these activators, 
such as CoCl 2 , may not be suitable for potential therapeutic applications because of their toxicity. We explored the use of DFX and PA, because the former is a drug approved for clinical use and the latter is a biological product, physiological for the organism, whose costimulatory activity on Mf activation is documented. 17, 22 We found that both DFX and PA are excellent inducers of IFNg in HRE-IFN-Mf, more potent than hypoxia as measured by the release/production of IFNg and the response to it. Neither stimulus caused a functional response in control Mf or parental Mf in agreement with what was observed previously. 18 As a result of the secretion of IFNg, HRE-IFN-Mf vectors displayed increased expression of IRF-1, which preludes to the activation of IFNg-inducible genes. Indeed, the 2 0 -5 0 OAse was strongly augmented by PA or DFX.
PA and DFX are relevant costimuli for HRE-IFN-Mf because they can trigger the production of NO, an important effector and regulatory molecule and a marker for full Mf activation, which is produced by the conversion of arginine to citrulline catalyzed in Mf by the iNOS enzyme. Hypoxia in combination with IFNg induces iNOS gene transcription and translation, but NO is not formed because the reaction requires molecular oxygen.
14 PA and DFX differ substantially from hypoxia because, by stimulating iNOS expression in HRE-IFNMf under normoxic conditions, they promote the enzyme under conditions in which the enzymatic activity can occur, and NO is produced. NO production by HRE-IFN-Mf could be responsible for the limited but significant apoptosis observed following treatment with PA or DFX. The production of NO coupled with the strong phagocytic activity that we have observed in response to PA or DFX points to the microbicidal activity as one of the relevant applications of these vectors. Furthermore, the induction of apoptosis may contribute to the destruction of mycobacteria, as shown in PAtreated Mf. 28 PA can be used pharmacologically and it has been tested on human patients as a chelating agent. 29 Furthermore, PA is a molecule that can be produced in pathological tissues. We have found a concentration of 40 mM PA in human serum of patients with degenerative liver diseases, 30 and higher concentrations could be reached in the intercellular space. We are exploring the use of our vectors for liver disease specifically where IFNg could be beneficial, as in the case of viral infection, and/or when endogenous PA could trigger the transcription of the therapeutic gene.
Unstimulated, normoxic HRE-IFN-Mf are constitutively positive for Ia antigen expression differing from the parental cells that are mainly Ia negative. 31 It is possible that threshold amounts of IFNg driven by the Tk minimal promoter are responsible for this effect. Low constitutive IFNg production could also account for the increase in 2 0 -5 0 OAse with time in culture (Figure 3b ). The induction of Ia antigens by PA or DFX followed a classical pattern of the induction by IFNg, reaching a strong increase above the constitutive levels. Ia induction seems unrelated to proliferation that was either unchanged or inhibited by the treatments. These results suggest a potential for HRE-IFN-Mf vectors to serve as antigen-presenting cells. The value of Mf vectors constitutively expressing the IFNg gene was demonstrated. 7, 8 PA and DFX share the property of chelating divalent cations, including iron and zinc, and evidence exists that their biological activities involve iron chelation. 15, 18, 21 We demonstrated that the addition of iron can block the activation of HRE-IFN-Mf by PA and DFX. These results suggest that local changes in iron concentration can modulate the sensitivity of HRE-IFN-Mf to PA and DFX. Furthermore, the antagonistic effects of iron on the activation of HRE-IFN-Mf vectors by PA or DFX represent an additional tool for the pharmacological control of the activation stage of this vector. The net activation profile of HRE-IFN-Mf can be nicely tuned utilizing different agents. PA and DFX will allow to exploit the full toxic potential of HRE-IFN-Mf, whereas hypoxia will prevent full activation and NO production, and iron will counteract and limit the effects of the stimuli. Furthermore, PA and DFX may exert antitumor activity 21, 32 by direct interaction with the tumor cells, suggesting that the application of PA or DFX and HRE-IFN-Mf in cancer treatment may be particularly beneficial because the tumor cell may be hit by the therapeutic gene, the costimulus, the activated Mf vector and the tumor-infiltrating leukocytes that may be rescued from their anergy by the proximity with IFNg-secreting cells. In general, the crafty choice of Mf vectors and HRE activators will steer their functional activity to generate the desired biological response.
Finally, we should consider that the physiological activation of Mf requires the collaboration between immune system-and host-derived signals. HRE-IFN-Mf become fully activated in response to environmental stimuli alone without the need for the contribution of the immune system, and they may be particularly beneficial in immunodepressed patients such as AIDS patients or cancer patients treated with chemotherapy.
In conclusion, the inducible Mf vector is a multifaceted system endowed with sufficient versatility to be tailored to different situations and tissues. The degree of activation of the vector itself is controlled by the biological activities of the therapeutic gene, by the inducing signals and by their interaction. The efficacy of the inducible Mf vectors will depend on the tissue distribution, extent of tissue infiltration, control at several levels of the therapeutic gene by the vector and effects of the therapeutic gene and of its inducers on the host cells. This technology must be further developed in preclinical models before considering this system for clinical application. Translational application requires the manipulation of primary cells to be used as a source of Mf. 33 The possibilities of transducing bone marrow stem cells and to differentiate them into Mf or of engineering human mononuclear cells in vitro are reasonable approaches to obtain engineered Mf, 5, 6, 34 and experiments are underway to address these issues.
Materials and methods

Cell culture
The mouse Mf cell line ANA-1 was established by infecting fresh bone marrow-derived cells from C57BL/6 mice with the J2 recombinant retrovirus, carrying the v-raf/v-myc oncogenes. 31 ANA-1 Mf were cultured in 
Reagents
Mouse rIFNg (sp. act. X10 7 U/mg) was purchased from GIBCO Laboratories, Grand Island, NY, USA. DFX, ferrous sulfate (purity D99%) and PA (purity D99%) were purchased from Sigma Chemical Company (St Louis, MO, USA). PA was dissolved in phosphatebuffered saline (PBS), and the pH was adjusted to 7.4. Stock solutions were passed through a 0.2 mm filter, aliquoted and stored at -201C. During the course of the experiments, several batches of PA and DFX were used, and all of them gave consistent and reproducible results. The content of endotoxin in all the reagents was below the detection limit of 6 pg/ml, as determined by the chromogenic Limulus amebocyte lysate test (Whittaker Bioproducts).
Plasmid generation
The pHRE3-Tk-IFNg shown in Figure 1 was generated as described previously. 11 Briefly, three tandem copies of the oligonucleotide 5 0 -AGTGACTACGTGCTGCCTAGG-3 0 (iNOS-HRE) were subcloned into the HindIII/BamHI sites of pBLCAT2, 5 0 upstream to the herpes simplex virus thymidine kinase (HSV-Tk) minimal promoter. The fragment encompassing the three tandem copies of iNOS-HRE, the HSV-Tk promoter fragment and the CAT gene was digested in HindIII/KpnI sites, klenowed in the HindIII site and subsequently inserted in the NruI/ KpnI sites of the pcDNA3 vector. The CAT-SV40 pA fragment was then deleted, and the IFNg cDNA, previously subcloned into the pBluescript vector, was subsequently inserted into the same sites. Control plasmid (p-control) was constructed by excising the 3xHRE from pHRE3x-Tk-IFNg.
Cell transfection
The transfectants Mf, HRE-IFN-Mf and Contr-Mf, were generated by electroporating ANA-1 cells with the plasmids pHRE3-Tk-IFNg and p-Control, respectively. Briefly, cells were washed and resuspended in complete medium at 25 Â 10 6 cells/ml. A total of 10 mg of plasmid DNA were added, and cell suspension was incubated for 10 min on ice, electroporated at 240 mV/ 975 mF (BioRad Gen Pulser II) and incubated for additional 10 min on ice. Cells were, then, washed twice in complete medium and plated onto 100 mm plates (Costar Companies, Cambridge, MA, USA). After 48 h of culture, stable transfectants were selected in medium containing 1 mg/ml G418 (ICN Biomedicals, Inc., Aurora, OH, USA), and bulk populations were used in all subsequent experiments. 
Northern blot analysis
Western blot analysis
Cells were lysed at 1 Â 10 8 cells/ml in lysis buffer (25 mM Tris, pH 7.6, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% SDS, 0.5% Na deossicolate, 0.5% NaN 3 , 1 mM [4-(2-aminoethyl)benzenesulfonyl-fluoride hydrochloride], 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin). After 10 min of incubation on ice, the lysates were spun at approximately 8000 Â g at 41C for 10 min. The supernatants were stored at À701C and tested for IRF-1 contents. The protein concentration was determined with the Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA). Total protein (100 mg) were subjected to 10% SDS-PAGE, electrophoresed under reducing conditions, and a Western blot analysis was performed. Briefly, proteins were transferred to Immobilon-P membrane (Millipore Corp. Bedford, MA, USA) by electroblotting at 300 mA for 2 h at 41C. The membrane was blocked with 5% nonfat dry milk for 2 h at room temperature and subsequently incubated with anti-mouse IRF-1 mAb (Santa Cruz Biotechnology, Santa Cruz, CA, USA) (2 mg/ml) for 1 h at room temperature with gentle shaking. The membrane was then washed and incubated with horseradish peroxidase-conjugated Protein A (Pierce, Rockford, IL, USA). IRF-1 protein expression was determined by enhanced chemioluminescent assay kit (Pierce, Rockford, IL, USA).
Immunofluorescence analysis
Mf were washed with PBS supplemented with 2% fetal bovine serum and 0.05% NaN 3 , and preincubated for 20 min at 41C with the anti-mouse CD16/CD32 rat mAb purchased from PharMingen (San Diego, CA, USA) to block Fcg III/II receptors-dependent nonspecific staining. Cells were then incubated for 30 min at 41C with FITC-conjugated monoclonal anti mouse Ia b or control IgG2a antibody (PharMingen, Hamburg, Germany). Surface staining was analyzed using a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA).
Cytokine determination
Cells were cultured onto 15-cm plates at 10 6 cells/ml and incubated with the appropriate stimuli. After incubation, cell-free supernatants were harvested and assayed for IFNg or TNFa protein using specific ELISA assays from Genzyme Corp. (Cambridge, MA, USA), following the manufacturer's instructions.
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Cell cycle analysis
A total of 5 Â 10 5 cells were washed twice with ice-cold PBS, fixed in 70% ice-cold ethanol for 30 min, stained with 50 mg/ml propidium iodide (Sigma, Milano, Italy) in 0.1% sodium citrate, 0.1% Triton X-100, 100 mg/ml DNase-free RNase (Roche Molecular Chemicals) and incubated in the dark for 1 h at 401C. DNA content was determined by flow cytometry (FACScan, Becton Dickinson, Mountain View, USA) using 488 nm excitation and 575 þ 26 nm detection. The data were analyzed using CELLQuest software (BD).
Nitrite assay
NO production was evaluated as NO 2 À accumulation.
14 Briefly, cell-free supernatants were incubated with the Griess reagent for 10 min at room temperature, and the absorbance was measured in a Diamedix BP-96 microplate reader at 550 nm (Delta Biologicals, Rome, Italy). The concentration of NO 2 À was determined by the square linear regression analysis of a sodium nitrite standard that was measured in each experiment. The limit of sensitivity of the NO 2 À assay was 1.5 mM.
Phagocytosis analysis
Phagocytosis analysis was performed by using the Zymosan reagent (Sigma Chemical Company, St Louis, MO, USA) previously opsonized by incubation in complete serum at the concentration of 5 mg/ml for 1 h at room temperature. Mf were incubated for 5 h at 371C with opsonized zymosan at the final concentration of 0.5 mg/ml. After incubation, cells were purified from undigested yeast particles through Ficoll-Hypaque gradient (Pharmacia) and washed three times in PBS 1 Â . Then, cells (1 Â 10 4 ) were applied to Polysine glass slides by centrifuging at 900 r.p.m. for 10 min, using a cytocentrifuge (Shandon, Cheshire, UK), fixed in methanol and stained with Giemsa dye (Sigma). Phagocytic activity was evaluated by counting opsonized zymosan particles ingested by 100 Mf/slide of three replicate slides in each experiment. The observer was blinded to the culture conditions.
